Home

Henryschein Dental Company (HSIC)

66.06
+0.42 (0.64%)
NASDAQ · Last Trade: Sep 28th, 3:48 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Why Henry Schein (HSIC) Shares Are Trading Lower Today
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) fell 2.7% in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs. 
Via StockStory · September 25, 2025
What Analysts Are Saying About Henry Schein Stockbenzinga.com
Via Benzinga · September 23, 2025
Henry Schein Sees Steady Smile As Dental Market Growth Holds: Analystbenzinga.com
Henry Schein sees steady dental market trends, with Piper Sandler expecting stronger equipment growth in the second half of 2025.
Via Benzinga · September 23, 2025
Dental Equipment & Technology Stocks Q2 Recap: Benchmarking Henry Schein (NASDAQ:HSIC)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at dental equipment & technology stocks, starting with Henry Schein (NASDAQ:HSIC).
Via StockStory · August 28, 2025
Earnings Scheduled For August 5, 2025benzinga.com
Via Benzinga · August 5, 2025
What Does the Market Think About Henry Schein?benzinga.com
Via Benzinga · July 17, 2025
1 S&P 500 Stock for Long-Term Investors and 2 We Question
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Via StockStory · August 27, 2025
What Analysts Are Saying About Henry Schein Stockbenzinga.com
Via Benzinga · August 26, 2025
This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesdaybenzinga.com
Via Benzinga · August 26, 2025
HSIC Q2 Deep Dive: Margin Pressures Persist Despite Solid Revenue, New Initiatives Announced
Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.3% year on year to $3.24 billion. Its non-GAAP profit of $1.10 per share was 7.6% below analysts’ consensus estimates.
Via StockStory · August 13, 2025
Deep Dive Into Henry Schein Stock: Analyst Perspectives (6 Ratings)benzinga.com
Via Benzinga · August 6, 2025
Top S&P500 movers in Tuesday's sessionchartmill.com
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.
Via Chartmill · August 5, 2025
Why Henry Schein (HSIC) Shares Are Falling Today
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) fell 9.7% in the afternoon session after the company reported second-quarter earnings that missed profit expectations and showed a year-over-year decline. 
Via StockStory · August 5, 2025
Henry Schein (HSIC) Q2 EPS Drops 11%fool.com
Via The Motley Fool · August 5, 2025
Which S&P500 stocks are moving on Tuesday?chartmill.com
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.
Via Chartmill · August 5, 2025
What's going on in today's session: S&P500 gap up and gap down stockschartmill.com
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index.
Via Chartmill · August 5, 2025
Henry Schein's 2025 Outlook Hinges On Strong Second-Half Executionbenzinga.com
Henry Schein Inc. stock down on Q2 earnings, misses EPS but beats sales. Total net sales up 3.3%, $23M in restructuring costs. FY2025 guidance affirmed.
Via Benzinga · August 5, 2025
Discover the top S&P500 movers in Tuesday's pre-market session.chartmill.com
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Via Chartmill · August 5, 2025
Henry Schein’s (NASDAQ:HSIC) Q2 Earnings Results: Revenue In Line With Expectations
Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.3% year on year to $3.24 billion. Its non-GAAP profit of $1.10 per share was 7.6% below analysts’ consensus estimates.
Via StockStory · August 5, 2025
Henry Schein (HSIC) Reports Earnings Tomorrow: What To Expect
Dental and medical products company Henry Schein (NASDAQ:HSIC) will be reporting results this Tuesday morning. Here’s what investors should know.
Via StockStory · August 3, 2025
Assessing Henry Schein: Insights From 6 Financial Analystsbenzinga.com
Via Benzinga · July 25, 2025
Nasdaq To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Fridaybenzinga.com
Via Benzinga · July 25, 2025
This Norfolk Southern Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Fridaybenzinga.com
Via Benzinga · July 25, 2025
Acadia Healthcare, Henry Schein, The Pennant Group, Ziff Davis, and Atlassian Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally. The positive sentiment swept across markets after it was announced the U.S. and Japan had reached a new trade deal. The agreement included a 15% tariff on Japanese goods imported into the U.S. and a commitment from Japan to invest $550 billion in the U.S. and open its markets to American cars and agricultural products. This development boosted investor confidence and contributed to a widespread rally, lifting stocks across many sectors. The Dow Jones Industrial Average and the S&P 500 both posted gains, creating a favorable environment that likely benefited individual stocks.
Via StockStory · July 23, 2025
ZimVie Doubles — And Then Some — On Its Second Takeover Dealinvestors.com
The Zimmer Biomet spinoff is looking to head for private waters under the fund Archimed.
Via Investor's Business Daily · July 21, 2025